Beneficial effects of buprenorphine (a partial opiate agonist) in porcine Escherichia coli septicaemia: a comparison with naloxone

Circ Shock. 1988 Jul;25(3):209-21.

Abstract

The cardiovascular and metabolic responses to treatment with naloxone or buprenorphine (a partial opiate agonist) were investigated in a porcine model of septicaemia. Animals anaesthetised with alpha-chloralose were infused with live E. coli over two hours. They were then divided into three groups and received either naloxone (2 mg kg-1 + 1.5 mg kg-1 hr-1) or buprenorphine (0.3 mg kg-1) or an equivalent volume of normal saline. Treatment was started one hour after commencing the infusion, by which time a significant fall in cardiac index (CI), stroke index (SI), mean arterial pressure (MAP), and pH had occurred in all groups, together with a significant rise in mixed venous blood lactate and packed cell volume. Treatment with both naloxone and buprenorphine resulted in significant improvements in CI, pH, and base excess and in a fall in mixed venous lactate and packed cell volume. Although no significant effect on survival was seen at three hours after the start of treatment, buprenorphine may prove to be a suitable alternative to naloxone in the management of septic shock.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Buprenorphine / pharmacology*
  • Cardiac Output / drug effects
  • Disease Models, Animal
  • Erythrocyte Indices / drug effects
  • Escherichia coli Infections*
  • Female
  • Lactates / blood
  • Naloxone / pharmacology*
  • Shock, Septic / blood
  • Shock, Septic / drug therapy
  • Shock, Septic / physiopathology*
  • Swine

Substances

  • Lactates
  • Naloxone
  • Buprenorphine